Delivery Order SPE2DB20D1100-SPE2DB25FE3V6
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,548.09 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100-count units). This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of August 12, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $1,953.40 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of dextroamphetamine-amphetamine 10 mg capsules (100 count). This firm fixed price contract, which is not set-aside, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The performance location is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a $14,269.44 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100 count). This is a firm fixed price, non-set-aside contract with a completion date of August 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $2,085.46 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 capsules of 30mg Dextroamp-Amphet ER. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility from September 19-20, 2023. As a major supplier of pharmaceuticals to the Department of Defense, this order for extended release dextroamphetamine capsules is consistent with DLA's mission to procure medical supplies and support the health of...
- The Defense Logistics Agency awarded a Delivery Order valued at $1,940.06 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count units) on August 12, 2025, with completion scheduled for August 13, 2025. This firm fixed price, non-set-aside contract was performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract executed under a larger Indefinite Delivery Contract vehicle with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,802.34 to AmerisourceBergen Drug Corp for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100-count units). This firm fixed-price delivery order, awarded on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a non-competitive award under an existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves...
- The Defense Logistics Agency awarded a $342,360 delivery order to Amerisourcebergen Drug Corporation for Dextroamphetamine ER 15 mg capsules. Under this firm fixed price contract, Amerisourcebergen will provide 100,000 capsules to support the Department of Defense's medical supply needs. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from July 25-26, 2023. No set aside designation or subcontractors were identified. This delivery...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Dextroamphetamine SR Caps 15mg, a controlled-release central nervous system stimulant medication. This firm fixed-price delivery order, valued at $6,915.33, represents a competitive award with no set-aside designation and is scheduled for completion by August 26, 2025. The contract will be performed at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for dextroamphetamine-amphetamine 10 mg capsules (100-count units) with a ceiling value of $1,597.36. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. The contract is set to complete by July 22, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Dextroamphetamine SR Capsules 15mg, with a ceiling value of $7,992.76. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 19, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a non-set-aside award, indicating the...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE3V6Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $4,635.56 firm fixed-price delivery order on August 29, 2025, for Dextroamphetamine ER 15 mg capsules (90-count units), with completion targeted for September 2, 2025. This non-set-aside award was issued to the vendor's Corporate Office located in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion pharmaceutical prime vendor vehicle valued through December 2026 that enables the company to supply comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company has demonstrated consistent capability to fulfill federal medical supply requirements through competitive awards across a broad portfolio of pharmaceutical products, including specialty medications, brand-name and generic drugs, and medical devices. This specific delivery order for dextroamphetamine represents one of numerous competitively awarded transactions the company executes under its DLA framework, reflecting its role as a key supplier within the military's pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 8/29/25 |